LONDON--()--By 2017 the urological catheters market is expected to be worth over $3 billion, according to a new report available on companiesandmarkets.com. Factors contributing to this robust growth include the rising incidence and diagnosis of urological conditions, advancements in catheter technology, and an increasingly ageing population.
Urological Catheters: A Global Strategic Business Report
Urological catheters - or renal catheters - are used across all medical settings, from hospitals to nursing homes, to treat urological conditions such as urinary incontinence, and conduct dialysis.
The market is split into two segments: urinary and dialysis catheters. Urinary catheters include Foley Catheters, Intermittent Catheters, External/Condom Catheters, while dialysis catheters include Hemodialysis Catheters and Peritoneal Catheters.
Intermittent catheters are increasing market share for a number of reasons. Medicare, the US social insurance program for the disabled and over 65s, now offers patients reimbursement for up 200 catheters a month; while patients and medical professionals are selecting ICs for their non-invasive functionality, which considerably reduces the risk of infection.
Innovation is a key part of the urological catheters market, and the industry is currently focused on making improvements to catheter efficiencies, catheter failures, and reducing the potential for infection.
With their advanced medical infrastructures, the established European and US markets control the urological catheters industry, although the emerging markets will experience more rapid growth over the reporting period. The dialysis catheter market is dominated by the US, while Europe holds a larger share of intermittent catheters. e greater number of catheters used per patient.
The 498 page August 2011 report thoroughly examines the urological catheters market, including historical and forecast data from 2003 to 2017, within the following geographies: US, Canada, Japan, Europe, France, Germany, Italy, Rest of Europe, Asia-Pacific and Middle-East.
Over sixty industry participants are profiles within the urological catheters research report, such as: AngioDynamics, Inc., Astra Tech, Inc., Boston Scientific Corp., C R Bard, Inc., Bard Medical Division, Coloplast A/S, Cook Medical, Covidien Ltd., Hollister, Inc., Medline Industries, Inc., Rochester Medical Corporation and Rusch, Inc.,
